Panagiotis Triantafyllou

National and Kapodistrian University of Athens

Papers

Total Citations

H-Index

About

Panagiotis Triantafyllou is a leading urologic surgeon and researcher whose work is shaping the future of minimally invasive cancer care. His primary research areas include robotic surgery innovation and the management of recurrent prostate cancer. Triantafyllou’s major contribution lies in critically evaluating the next generation of robotic platforms beyond the long-dominant da Vinci system. His highly cited 2025 review, *Beyond Da Vinci*, has already garnered 8 citations, establishing him as a key voice in the transition toward more diverse, competitive robotic technologies. Additionally, his 2024 review on salvage radical prostatectomy for recurrent prostate cancer (4 citations) provides essential guidance for clinicians navigating complex treatment decisions after primary therapy failure. By synthesizing evidence on emerging robotic systems and salvage surgical techniques, Triantafyllou directly informs both clinical practice and surgical innovation. His work is essential reading for urologists and researchers aiming to understand the rapidly evolving landscape of robotic urologic surgery and the expanding therapeutic options for prostate cancer patients.